Obesity develops when energy intake exceeds energy expenditure, leading to an accumulation of adipose tissue. The pandemic of excess adipose tissue is of increasing importance throughout the world. In addition to its own specific morbidities, obesity is linked to insulin resistance and the devastating metabolic syndrome of type 2 diabetes. The intricate balance of energy homeostasis is tightly regulated by a complex network of metabolic genes which respond to changing environmental conditions. Transcriptional regulation has recently been shown to extensively modulate adipocyte biology. We have discovered that a novel transcriptional coregulator, TRIP-Br2, is critical for maintaining energy homeostasis in mice. Our preliminary data from preadipocyte cell lines and TRIP-Br2 null mice leads us to propose an important role of TRIP-Br2 in adipocyte biology. Thus, the goal of this proposal is to determine the function and mechanism of TRIP-Br2 in energy metabolism in adipose tissue. I will test the hypothesis that disruption of TRIP-Br2 protects mice from diet- induced obesity through upregulation of energy expenditure with three specific aims.
For Specific Aim 1, I will physically and physiologically examine the TRIP-Br2 null mice to identify the in vivo mechanism for diet- induced obesity resistance observed in TRIP-Br2 KO mice. Completion of Aim 1, which will take place during K99 phase, will provide me with training in aspects of in vivo and ex vivo adipose physiology necessary to independently complete the R00 phase.
For Specific Aim 2, which will span the K99 and R00 phases, I will determine the molecular targets of TRIP-Br2 that contribute to the diet-induced obesity resistance phenotype in TRIP-Br2 null mice using genome-wide gene and protein expressions together with bioinformatics analysis. Completion of the subaim of Aim 2 proposed during the K99 phase will provide me with the training in analysis of complex datasets with computational biology necessary to independently to complete Aim 2 during the R00 phase.
For Specific Aim 3 (R00 phase), I will determine the composition of TRIP-Br2 transcriptional regulatory complex in adipocytes. Completion of this aim will allow me to link the TRIP-Br2 regulatory network with known gene regulatory system in adipocyte. These experiments are novel in that they combine mouse genetic, physiologic, and molecular biology approaches to examine the mechanistic role of TRIP-Br2 in energy metabolism. These studies will provide novel insights into the transcriptional regulation of adipocyte function and could potentially be used for developing therapeutic targets for obesity.

Public Health Relevance

Obesity is a critical health problem in the US because it leads to fatal complications. These studies will determine the mechanisms contributing to high fat diet-induced obesity resistance in our mouse model. Understanding the gene targets will facilitate development of therapeutic strategies.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Research Transition Award (R00)
Project #
Application #
Study Section
Special Emphasis Panel (NSS)
Program Officer
Haft, Carol R
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Illinois at Chicago
Schools of Medicine
United States
Zip Code
Qi, Weier; Li, Qian; Liew, Chong Wee et al. (2017) SHP-1 activation inhibits vascular smooth muscle cell proliferation and intimal hyperplasia in a rodent model of insulin resistance and diabetes. Diabetologia 60:585-596
Liew, Chong Wee; Xu, Shanshan; Wang, Xuerong et al. (2017) Multiphasic Regulation of Systemic and Peripheral Organ Metabolic Responses to Cardiac Hypertrophy. Circ Heart Fail 10:
Kawamori, Dan; Shirakawa, Jun; Liew, Chong Wee et al. (2017) GLP-1 signalling compensates for impaired insulin signalling in regulating beta cell proliferation in ?IRKO mice. Diabetologia 60:1442-1453
Qi, Weier; Keenan, Hillary A; Li, Qian et al. (2017) Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction. Nat Med 23:753-762
Qiang, Guifen; Whang Kong, Hyerim; Gil, Victoria et al. (2017) Transcription regulator TRIP-Br2 mediates ER stress-induced brown adipocytes dysfunction. Sci Rep 7:40215
Qiang, Guifen; Whang Kong, Hyerim; Xu, Shanshan et al. (2016) Lipodystrophy and severe metabolic dysfunction in mice with adipose tissue-specific insulin receptor ablation. Mol Metab 5:480-490
Qiang, Guifen; Kong, Hyerim Whang; Fang, Difeng et al. (2016) The obesity-induced transcriptional regulator TRIP-Br2 mediates visceral fat endoplasmic reticulum stress-induced inflammation. Nat Commun 7:11378
El Ouaamari, Abdelfattah; Dirice, Ercument; Gedeon, Nicholas et al. (2016) SerpinB1 Promotes Pancreatic ? Cell Proliferation. Cell Metab 23:194-205
Bhatt, Shweta; Gupta, Manoj K; Khamaisi, Mogher et al. (2015) Preserved DNA Damage Checkpoint Pathway Protects against Complications in Long-Standing Type 1 Diabetes. Cell Metab 22:239-52
O-Sullivan, InSug; Zhang, Wenwei; Wasserman, David H et al. (2015) FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization. Nat Commun 6:7079

Showing the most recent 10 out of 19 publications